Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this
Grifols is a global health company that develops, manufactures, and markets innovative medicines, plasma-derived therapies, diagnostics, and hospital solutions across more than 110 countries. Its key areas include immunology, hepatology and intensive care, pulmonology, hematology, neurology, infectious diseases, and other opportunities, supported by extensive plasma science and programs like CHRONOS-PD. The company emphasizes sustainability, ethics, and social commitment, including supporting patients and plasma donors, and maintains a broad R&D network to drive future breakthroughs.
Words AI uses
AI reaches for operates many centers · massive · varies when it describes Grifols Plasma.
Sources
goodrx.com shapes more of what AI says about Grifols Plasma than any other source, at 19% of its citations.
grifolsplasma.com · scienceinsights.org · blood.ca · cloud.mail.grifolsdonorhub.com
The market map
Biotech and Health Service Providers →Where AI ranks Grifols Plasma
Excerpts where Grifols Plasma appeared in the AI's answer

Grifols Plasma : Operates under names like Biomat USA, Talecris Plasma Resources, and PlasmaCare.

Grifols Plasma : A massive international network operating under local brand names like Biomat USA, Talecris Plasma Resources, and PlasmaCare.